REGN institutional holders
REGENERON PHARMACEUTICALS COM · 13F, 2026Q2
| Managers holding | 1,332 |
|---|
| Shares held | 91,588,748 |
|---|
| Reported value | $57.2bn |
|---|
| Quarter flows | 122 new, 485 added, 538 trimmed, 189 exited |
|---|
Top 25 holders
| Manager | Shares | Value | % of manager's 13F |
|---|
| BlackRock, Inc. | 9,113,506 | $5.7bn | 0.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,629,759 | $4.1bn | 0.1% |
| Dodge & Cox | 4,871,137 | $3.0bn | 1.6% |
| STATE STREET CORP | 4,834,688 | $3.0bn | 0.1% |
| Invesco Ltd. | 3,940,665 | $2.5bn | 0.2% |
| JPMORGAN CHASE & CO | 3,774,199 | $2.4bn | 0.1% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3,175,313 | $2.0bn | 0.1% |
| FRANKLIN RESOURCES INC | 2,771,839 | $1.7bn | 0.4% |
| GEODE CAPITAL MANAGEMENT, LLC | 2,625,810 | $1.6bn | 0.1% |
| Nuveen, LLC | 2,019,974 | $1.3bn | 0.3% |
| LOOMIS SAYLES & CO L P | 1,859,172 | $1.2bn | 1.5% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,529,709 | $953.8m | 0.1% |
| MORGAN STANLEY | 1,397,712 | $871.5m | 0.0% |
| BANK OF AMERICA CORP /DE/ | 1,291,053 | $805.0m | 0.1% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,270,087 | $792.0m | 0.1% |
| NORGES BANK | 1,172,808 | $731.3m | 0.1% |
| GOLDMAN SACHS GROUP INC | 1,163,191 | $725.3m | 0.1% |
| AQR CAPITAL MANAGEMENT LLC | 1,126,080 | $702.2m | 0.2% |
| Amundi | 1,013,540 | $632.0m | 0.2% |
| NORTHERN TRUST CORP | 916,467 | $571.5m | 0.1% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 846,306 | $527.7m | 0.1% |
| FMR LLC | 831,964 | $518.8m | 0.0% |
| Capital World Investors | 814,925 | $508.1m | 0.1% |
| Legal & General Group Plc | 759,971 | $473.9m | 0.1% |
| Bank of New York Mellon Corp | 758,492 | $473.0m | 0.1% |
Every holder, line by line, and the full history since 2013: yf.Client().holders("REGN"). REGN price history · All 13F data
Get a free API keySee history bundlesDownload free samples